Literature DB >> 6539333

Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.

F M Booyse, G Osikowicz, S Feder, J Scheinbuks.   

Abstract

A urokinase-type plasminogen activator secreted by subcultured normal human umbilical vein endothelial cells was purified and compared to urinary urokinase (Mr = 54,000). The enzyme was isolated from serum-free conditioned medium in the presence of 0.1% (v/v) Triton X-100 by p-aminobenzamidine-agarose affinity chromatography, followed by Sephacryl S-200 gel filtration, followed by immunoadsorption chromatography on affinity purified specific anti-urokinase IgG-Sepharose CL-4B. This plasminogen activator form was obtained from the culture medium with a yield of about 47% and specific activity of about 93,000 IU/mg of protein, and represented approximately 18% of the total multiple molecular plasminogen activator activity forms present in endothelial cell conditioned medium. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the purified enzyme showed a single band of plasminogen activator activity with an estimated molecular weight of about 54,000 that was completely inhibited by diisopropyl fluorophosphate (DFP) as well as a single band of radioactivity with similar molecular weight for both the isolated L-[4,5-3H]leucine and [3H]DFP-labeled enzyme. The radiolabeled protein focused as a single major band with a pI value of pH 8.5. The endothelial cell activator and urokinase appeared to be identical in terms of sodium dodecyl sulfate-polyacrylamide gel electrophoresis, location of the [3H]DFP-labeled active site in the Mr = 33,000 heavy chain and [3H]DFP-labeled active site tryptic peptide, and two-dimensional 125I-labeled tryptic peptide maps. In quenching experiments of the fibrinolytic activities using affinity purified specific anti-urokinase IgG the endothelial cell-derived activator and urokinase appeared to be immunochemically identical, but unrelated to tissue plasminogen activator. These results indicate that the Mr = 54,000 urokinase-type plasminogen activator from cultured normal human endothelial cells is similar to, or identical with, Mr = 54,000 urinary urokinase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539333

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Variability in messenger RNA levels in human umbilical vein endothelial cells of different lineage and time in culture.

Authors:  D Dichek; T Quertermous
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

2.  [Significance of the endothelium of the vascular wall for maintaining hemostasis].

Authors:  U Delvos; G Müller-Berghaus
Journal:  Klin Wochenschr       Date:  1985-12-16

3.  Plasminogen activator inhibitor-type I is a major biosynthetic product of retinal microvascular endothelial cells and pericytes in culture.

Authors:  A E Canfield; A M Schor; D J Loskutoff; S L Schor; M E Grant
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

4.  Identification and partial characterization of two major proteins of Mr 47,000 synthesized by bovine retinal endothelial cells in culture.

Authors:  A E Canfield; A M Schor; D C West; S L Schor; M E Grant
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

5.  Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.

Authors:  K A Hajjar; R L Nachman
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

6.  Binding of tissue plasminogen activator to cultured human endothelial cells.

Authors:  K A Hajjar; N M Hamel; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

7.  Close similarity between cultured human omental mesothelial cells and endothelial cells in cytochemical markers and plasminogen activator production.

Authors:  K Takahashi; J Hata; K Mukai; Y Sawasaki
Journal:  In Vitro Cell Dev Biol       Date:  1991-07

8.  Longistatin, a plasminogen activator, is key to the availability of blood-meals for ixodid ticks.

Authors:  M Khyrul Islam; M Abdul Alim; Takeharu Miyoshi; Takeshi Hatta; Kayoko Yamaji; Yasunobu Matsumoto; Kozo Fujisaki; Naotoshi Tsuji
Journal:  PLoS Pathog       Date:  2011-03-10       Impact factor: 6.823

9.  Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.

Authors:  N Toki; H Sumi; K Sasaki; I Boreisha; K C Robbins
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

10.  Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood.

Authors:  D Menzel; M Levi; G Dooijewaard; M Peters; J W ten Cate
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.